ESR1 and breast carcinoma: With the aim of exploring metabolic vulnerabilities of these breast cancer subtypes, we analyzed ROS production, the efficiency of ROS-handling systems and energetic metabolism in a panel of breast cancer cell lines belonging to the ER+ or TN subtypes of the disease.